Marketing Agreement - UTEK Corp. and Wolfram Weinsheimer
Wolfram Weinsheimer, M.D.
Kuerzlengraben 15A
D-89275 Elchingen
Germany
April 15, 1999
Dear Dr. Weinsheimer:
As Uwe discussed with you during his visit to Heidenheim, UTEK
Corporation would like to engage your services as an independent marketing
representative. Your duties would be to introduce UTEK to CEO's of public
companies for the purpose of having UTEK be engaged by these companies to find,
acquire and transfer technology licenses to them. Your services will be rendered
as an independent contractor and not as an employee of UTEK. Uwe and I will
provide some assistance to you to help ensure that you can make a knowledgeable
and effective sales presentations.
We would like you to provide these services on a time available basis,
where you decide how much effort and time you will spend soliciting
prospects/customers for UTEK. You are free to provide these services at a
location of your choice. You must cover your own expenses while providing this
service.
In consideration for providing this service to the company, UTEK will
compensate you with 10% of any monies or stock received from a customer you
introduce to UTEK, within one week following the closing of a technology
transfer agreement between this customer and UTEK.
The term of this Agreement is 12 months. This Agreement may be
cancelled by either party upon 90 days notice.
This Agreement is governed by the Laws of the State of Florida, USA.
If you agree with all of the above terms, please sign and send a copy
of this letter to Uwe or me. Dr. Weinsheimer, we really look forward to working
with you in the months to come.
Very best regards,
/s/ Clifford M. Gross
Clifford M. Gross, Ph.D.
Chief Executive Officer
Agreed to:
/s/ Dr. Wolfram Weinsheimer 99-5-4
------------------------------------------------------------------------
Dr. Wolfram Weinsheimer, M.D. Date
March 28, 2000
Dr. Wolfram Weinsheimer
Kuerzlengraben 15A
D-89275 Elchingen, Germany
Dear Wolfram:
I hope all is well. In preparation for our public offering, we will be
operating as a business development corporation, which has its own legal
requirements. Accordingly, we will no longer be able to compensate regional
representatives with shares of stock in companies who acquire technologies from
us.
Instead of the current 10% equity commission upon the consummation of
any successful technology transfer (which results from your efforts), we will
now provide you with a $20,000 cash commission upon the successful sale of a
UTEK licensed technology.
If you agree to this new commission program, please sign below and fax
back to Carole Mason, CFO, by April 12th, 2000.
I appreciate all of your efforts to-date and look forward to our
continued mutually beneficial relationship.
Very best regards,
/s/ Uwe Reischl
Uwe Reischl, Ph.D., M.D.
President
Cc: Sam Reiber
Agreed to: /s/ Dr. Wolfram Weinsheimer Date 00-04-06
-------------------------------------- -------------